ESRRB and cervical cancer: Nonetheless, this study revealed that ESRRB was overexpressed in cervical cancer and linked with disease progression, whereas ESRRB knockout in cervical cancer cells triggered cell-cycle arrest, causing interference of cell proliferation in vitro and diminished tumor growth in vivo.